Neuphoria Therapeutics (NEUP) Cash Flow: Operating & Free Cash Flow

Neuphoria Therapeutics Cash Flow Statement Analysis

Values in billions AUD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Neuphoria Therapeutics Inc. (NEUP) - Annual data in billions AUD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017
Operating Activities
Net Income	-13.45	-0.37	-0.02	-0.02	-0.02	-0.01	0.00	-0.01	0.00	0.00
Depreciation & Amortization	0.66	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Income Tax	-0.14	-0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Based Compensation	0.35	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Working Capital	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Other Working Capital	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Activities	0.23	0.09	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00
Net Cash from Operating Activities	-12.35	0.08	-0.01	-0.01	-0.01	-0.01	0.00	-0.01	-0.02	0.00
Investing Activities
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchases of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financing Activities
Debt Repayment	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01	0.00	0.00	0.00
Common Stock Issued	0.02	0.00	0.01	0.00	0.02	0.03	0.00	0.01	0.00	0.00
Other Financing Activities	17.90	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash from Financing Activities	17.92	1.53	0.02	0.00	0.02	0.02	0.00	0.00	0.00	0.00
Summary
Effect of Forex Changes on Cash	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	5.58	1.60	0.00	-0.01	0.00	0.02	-0.01	-0.01	-0.01	0.00
Cash at Beginning of Period	14.29	12.69	0.01	0.02	0.02	0.00	0.01	0.02	0.03	0.05
Cash at End of Period	19.87	14.29	0.01	0.01	0.02	0.02	0.00	0.01	0.02	0.04
Free Cash Flow	-12.35	0.08	-0.01	-0.01	-0.01	-0.01	0.00	-0.01	-0.02	0.00
Supplemental Disclosures
Interest Paid	-	0.00	0.00	-	0.00	0.00	-	-	-	-
Income Taxes Paid	-	-	0.00	-	-	-	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Neuphoria Therapeutics Cash Flow

What is Neuphoria Therapeutics's free cash flow?

Neuphoria Therapeutics had negative free cash flow of AUD 12.35B in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −AUD 12.35B minus AUD 4.00 of capital expenditures.

How much does Neuphoria Therapeutics spend on capital expenditures?

Neuphoria Therapeutics spent AUD 4.00 on capital expenditures in fiscal 2026.

Does Neuphoria Therapeutics pay dividends or buy back shares?

Neuphoria Therapeutics's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition